ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase II Study of Increased-Dose Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01637402
Recruitment Status : Active, not recruiting
First Posted : July 11, 2012
Last Update Posted : June 8, 2017
Sponsor:
Collaborator:
Janssen, LP
Information provided by (Responsible Party):
Terence Friedlander, MD, University of California, San Francisco

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : March 2017
  Estimated Study Completion Date : December 2017